CDEK by Data4ThePeople
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
← All indications

Bleeding Time

Duration of blood flow after skin puncture. This test is used as a measure of capillary and platelet function.

Drugs by status

Phase 4 trials (3)

  • fibrinogen (human)
  • antihemophilic factor viii (Recombinant)
  • blood plasma

Phase 3 trials (10)

  • diclofenac
  • methylprednisolone
  • thrombomodulin alfa
  • autologous plasma
  • red blood cells
  • platelets
  • enoxaparin
  • whole blood
  • cryoprecipitate
  • unfractionated heparin

Phase 2 trials (9)

  • vitamin d3
  • vitamin e
  • human factor ix complex (prothrombin complex concentrate)
  • vitamin c
  • sivelestat
  • acetylsalicylic acid
  • cellulose
  • sodium chloride
  • camostat mesylate

Phase 1 trials (1)

  • bay3389934

Other trials (4)

  • desmopressin
  • epinephrine
  • immune globulin (human)
  • allogeneic blood cells

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.